How do I find out if I qualify for a metastatic pancreatic ductal adenocarcinoma study in Massachusetts?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Massachusetts to take part?

Not necessarily. These studies have a site in Massachusetts, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a metastatic pancreatic ductal adenocarcinoma trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Massachusetts

Metastatic Pancreatic Ductal Adenocarcinoma clinical trials in Massachusetts

We’re tracking 28 recruiting metastatic pancreatic ductal adenocarcinoma studies with a site in Massachusetts — including Phase 1 and Phase 1/Phase 2 studies, each written for real people, not researchers.

Recruiting studies in Massachusetts

NCT06835569RecruitingPhase 1
ALTA3263 for advanced KRAS-mutated solid tumors
This trial tests an experimental pill called ALTA3263 for adults with advanced solid tumors that have a specific KRAS mutation. It's for people who have already tried other treatments or can't take them.
Boston, MassachusettsAges 18 years+
NCT07020221RecruitingPhase 1/Phase 2
Study of VS-7375 for KRAS G12D solid tumors
This trial tests a new oral drug called VS-7375 for people with advanced solid tumors that have a specific KRAS G12D mutation. The goal is to see if it can shrink tumors or slow their growth.
Boston, MassachusettsAges 18 years+
NCT07458347RecruitingPhase 1
A new oral drug for KRAS-mutated advanced cancer
This trial tests a new oral drug, KST-6051, for people with advanced solid tumors (like lung, pancreatic, colon, or other cancers) that have a specific KRAS gene mutation. The goal is to find the best dose and see if it's safe.
Boston, MassachusettsAges 18 years+
NCT06451497RecruitingPhase 1
Testing ZM008 alone and with toripalimab for advanced cancers
This trial tests a new drug called ZM008, which targets a protein on some cancer cells, first alone and then combined with another drug, toripalimab, for people with advanced solid tumors that have stopped responding to standard treatments.
Boston, MassachusettsAges 18 years+

Metastatic Pancreatic Ductal Adenocarcinoma trials by city in Massachusetts

Boston

Where these studies are running in Massachusetts

Institutions with a site for the recruiting metastatic pancreatic ductal adenocarcinoma studies listed above.

Massachusetts General Hospital · 2 studies
Dana-Farber Cancer Institute
Research Site

What taking part in a metastatic pancreatic ductal adenocarcinoma study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Metastatic Pancreatic Ductal Adenocarcinoma trials in other states

Common questions

Are there metastatic pancreatic ductal adenocarcinoma clinical trials in Massachusetts?: Yes. We're currently tracking 28 recruiting metastatic pancreatic ductal adenocarcinoma studies with a site in Massachusetts, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a metastatic pancreatic ductal adenocarcinoma study in Massachusetts?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Massachusetts to take part?: Not necessarily. These studies have a site in Massachusetts, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a metastatic pancreatic ductal adenocarcinoma trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New metastatic pancreatic ductal adenocarcinoma studies open in Massachusetts regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.